Free Trial
LON:NIOX

NIOX Group 4/1/2025 Earnings Report

NIOX Group logo
GBX 76 +2.40 (+3.26%)
As of 12:35 PM Eastern

NIOX Group EPS Results

Actual EPS
GBX 2.27
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NIOX Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NIOX Group Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NIOX Group Earnings Headlines

UK Stocks Trading Below Estimated Value For July 2025
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
UK Stocks Trading Below Estimated Value In July 2025
UK Penny Stocks Under £500M Market Cap To Watch
UK Stocks That Might Be Priced Below Estimated Value
See More NIOX Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NIOX Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NIOX Group and other key companies, straight to your email.

About NIOX Group

NIOX Group (LON:NIOX) is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings. Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries. NIOX is committed to enabling more precise and personalised care for patients with respiratory conditions, with a focus on quality, innovation, and scientific excellence.

View NIOX Group Profile

More Earnings Resources from MarketBeat